• About Us
    • Overview
    • Management Team
      • Charles H Large
      • Giuseppe S. Alvaro
      • Daniel Umbricht
      • Barbara Domayne-Hayman
      • Martin Pue
      • Martin Gunthorpe
      • Hannah Selin
      • Wendy Kennedy
    • Board of Directors
    • Investors
  • Pipeline
    • Overview
    • Fragile X Syndrome
    • Orphan Epilepsy Syndromes
  • Science
  • Partnering
  • News & Events
    • Publications
  • Careers
  • Contact Us
  • Menu Menu

Autifony and collaborators publish the results from a clinical trial of AUT00206 in patients with schizophrenia

3 October 2022
Read more
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg 0 0 Wendy Kennedy https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg Wendy Kennedy2022-10-03 13:31:112022-10-04 11:08:41Autifony and collaborators publish the results from a clinical trial of AUT00206 in patients with schizophrenia

Autifony and collaborators publish the results from a clinical trial of AUT00206 in patients with schizophrenia

3 October 2022
Read more
https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg 0 0 Wendy Kennedy https://autifony.com/wp-content/uploads/2022/05/autifony_therapeutics-Logo_RGB.svg Wendy Kennedy2022-10-03 13:29:102022-10-03 13:29:10Autifony and collaborators publish the results from a clinical trial of AUT00206 in patients with schizophrenia
  • About Us
    • Overview
    • Management Team
      • Charles H Large
      • Giuseppe S. Alvaro
      • Daniel Umbricht
      • Barbara Domayne-Hayman
      • Martin Pue
      • Martin Gunthorpe
      • Hannah Selin
      • Wendy Kennedy
    • Board of Directors
    • Investors
  • Pipeline
    • Overview
    • Fragile X Syndrome
    • Orphan Epilepsy Syndromes
  • Science
  • Partnering
  • News & Events
    • Publications
  • Careers
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • LinkedIn
© Autifony Therapeutics
Website by FisherPaul
  • Privacy Policy
  • Terms & Conditions
Scroll to top